Tag: livestock

Avivagen Inc., a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting general health and performance, announced that it closed its previously announced offering of 15,000,000 units of the Company (the “Units”) on a “bought deal” basis, at a price of $0.50 per Unit (the “Offering Price”) for aggregate gross proceeds of $7,500,000 (the “Offering”).

'EuroTier / EnergyDecentral digital', DLG's new digital platform impresses with 41,000 participants over four days - 45 percent international participation - Great interest in the technical program with over 300 specialist events - videos available "on demand" from February 18 to April 15.

Avivagen announces six tons order of OxC-beta™ Livestock from new customer in Mexico. Significant and ongoing order complements previous ten tons order from established customer Industrias Melder.